Samuel B. Mabbott
Associate Professor
Also affiliated: Texas A&M University System (2022–2025); University of Strathclyde (2013–2019); Mitchell Institute (2019–2026); University of Manchester (2012–2017); International Union of Pure and Applied Chemistry (2015–2016); Glasgow Life (2013–2019); Technologies pour la Santé (2025); Czech Academy of Sciences, Institute of Biotechnology (2017); Texas A&M Health Science Center (2022); Center For Remote Sensing (United States) (2023–2025); Université Bourgogne Franche-Comté (2022–2025); Business Innovation Centre (2015); College Station Medical Center (2019); Texas A&M Engineering Experiment Station (2021–2025); Texas A&M University (2019–2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Samuel B. Mabbott's research focuses on the development and application of advanced spectroscopic techniques, particularly Surface-Enhanced Raman Scattering (SERS), for sensitive and specific detection of various analytes. His work has explored the use of SERS for identifying bacterial pathogens, detecting microRNAs associated with cardiovascular disease, and quantifying illicit substances. He has also investigated SERS for imaging biological samples, including live breast cancer tumor models, through tissue using handheld surface-enhanced spatially offset resonance Raman spectroscopy (SESORRS).
Mabbott's publications demonstrate a consistent interest in improving the capabilities of SERS, including the development of "extreme red shifted SERS nanotags." His research extends to the optimization of parameters for quantitative SERS detection and the application of portable Raman spectrometers. He has also contributed to understanding biomarkers and point-of-care screening approaches for conditions like preeclampsia.
His scholarly contributions are reflected in an h-index of 21, with 77 total publications and 1,227 citations. Mabbott's work has a clear translational aspect, aiming to advance diagnostic and screening capabilities in areas ranging from infectious diseases to cancer and cardiovascular health.
Metrics
- h-index: 21
- Publications: 77
- Citations: 1,227
Positions
-
Associate Professor 2018–presentTexas A&M University College of Engineering Biomedical Engineering ORCID
-
Associate Professor publications 2022–2026Arkansas Agricultural Experiment Station ORCID
-
Postdoctoral Research Associate 2012–2018University of Strathclyde Pure and Applied Chemistry ORCID
Selected Publications
-
A Hyperbranched Rolling Circle Amplification Assay Using Aptamer–Hemin/G-Quadruplex Recognition for the Detection of Creatine Kinase-MB (2026)
-
A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF) (2022)
Collaboration Network
Top Collaborators
- A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)
- A Hyperbranched Rolling Circle Amplification Assay Using Aptamer–Hemin/G-Quadruplex Recognition for the Detection of Creatine Kinase-MB
- A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)
- A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)
- A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)
- A Hyperbranched Rolling Circle Amplification Assay Using Aptamer–Hemin/G-Quadruplex Recognition for the Detection of Creatine Kinase-MB
- A Hyperbranched Rolling Circle Amplification Assay Using Aptamer–Hemin/G-Quadruplex Recognition for the Detection of Creatine Kinase-MB
- A Hyperbranched Rolling Circle Amplification Assay Using Aptamer–Hemin/G-Quadruplex Recognition for the Detection of Creatine Kinase-MB
Similar Researchers
Based on overlapping research topics